Influenza infection results in local expansion of memory CD8+ T cells with antigen non-specific phenotype and function

Clinical and Experimental Immunology

Volumn 175, Issue 1, 2014, Pages 79-91

  Sckisel, Gail D ^a,b   Tietze, Julia K ^a   Zamora, Anthony E ^a,b   Hsiao, Hua Hui ^a,f   Priest, Stephen O ^b   Wilkins, Danice E C ^d   Lanier, Louis L ^c   Blazar, Bruce R ^e   Baumgarth, Nicole ^b   Murphy, William J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antigen non specific; Bystander activation; Memory CD8; NKG2D; Tissue resident

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; HERMES ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; NATURAL KILLER CELL RECEPTOR NKG2D;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN FUNCTION; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; DISEASE COURSE; FEMALE; INFLAMMATION; INFLUENZA A; INFLUENZA VIRUS A; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION; VIRUS IMMUNITY; VIRUS REPLICATION; VIRUS STRAIN;

ANTIGEN NON-SPECIFIC; BYSTANDER ACTIVATION; MEMORY CD8; NKG2D; TISSUE-RESIDENT;

ANIMALS; ANTIGENS, CD40; BYSTANDER EFFECT; CD8-POSITIVE T-LYMPHOCYTES; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY; INFLUENZA A VIRUS; INTERLEUKIN-2; LUNG; MICE; MICE, TRANSGENIC; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; ORTHOMYXOVIRIDAE INFECTIONS; VIRUS REPLICATION;

EID: 84888857737     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12186     Document Type: Article

References (68)

1. Bi Z, Barna M, Komatsu T, Reiss CS. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J Virol 1995; 69:6466-6472.
2. Cousens LP, Orange JS, Biron CA. Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection. J Immunol 1995; 155:5690-5699.
3. Murata K, Garcia-Sastre A, Tsuji M etal. Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cell Immunol 1996; 173:96-107.
4. Sunil-Chandra NP, Arno J, Fazakerley J, Nash AA. Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Am J Pathol 1994; 145:818-826.
5. Jacoby RO, Bhatt PN, Brownstein DG. Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Arch Virol 1989; 108:49-58.
6. Doherty PC, Allan W, Eichelberger M, Carding SR. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu Rev Immunol 1992; 10:123-151.
7. Zinkernagel RM, Bachmann MF, Kundig TM, Oehen S, Pirchet H, Hengartner H. On immunological memory. Annu Rev Immunol 1996; 14:333-367.
8. Tripp RA, Hou S, McMickle A, Houston J, Doherty PC. Recruitment and proliferation of CD8+ T cells in respiratory virus infections. J Immunol 1995; 154:6013-6021.
9. Butz EA, Bevan MJ. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 1998; 8:167-175.
10. Murali-Krishna K, Altman JD, Suresh M etal. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998; 8:177-187.
11. Masopust D, Murali-Krishna K, Ahmed R. Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought. J Virol 2007; 81:2002-2011.
12. Doisne JM, Urrutia A, Lacabaratz-Porret C etal. CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J Immunol 2004; 173:2410-2418.
13. Lawrence CW, Ream RM, Braciale TJ. Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J Immunol 2005; 174:5332-5340.
14. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996; 272:1947-1950.
15. Sprent J, Zhang X, Sun S, Tough D. T-cell turnover in vivo and the role of cytokines. Immunol Lett 1999; 65:21-25.
16. McGill J, Van Rooijen N, Legge KL. IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection. J Exp Med 2010; 207:521-534.
17. Zhang X, Sun S, Hwang I, Tough DF, Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 1998; 8:591-599.
18. Ehl S, Hombach J, Aichele P, Hengartner H, Zinkernagel RM. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J Exp Med 1997; 185:1241-1251.
19. Sandalova E, Laccabue D, Boni C etal. Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans. PLOS Pathog 2010; 6:e1001051.
20. Ogasawara K, Lanier LL. NKG2D in NK and T cell-mediated immunity. J Clin Immunol 2005; 25:534-540.
21. Tietze JK, Wilkins DE, Sckisel GD etal. Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy. Blood 2012; 119:3073-3083.
22. Baumgarth N, Brown L, Jackson D, Kelso A. Novel features of the respiratory tract T-cell response to influenza virus infection: lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10. J Virol 1994; 68:7575-7581.
23. Baumgarth N, Kelso A. In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J Virol 1996; 70:4411-4418.
24. Alderson KL, Zhou Q, Berner V etal. Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapy. J Immunol 2008; 180:2981-2988.
25. Doherty PC, Christensen JP. Accessing complexity: the dynamics of virus-specific T cell responses. Annu Rev Immunol 2000; 18:561-592.
26. Eichelberger MC, Wang ML, Allan W, Webster RG, Doherty PC. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. J Gen Virol 1991; 72 (Pt 7):1695-1698.
27. Baumgarth N, Egerton M, Kelso A. Activated T cells from draining lymph nodes and an effector site differ in their responses to TCR stimulation. J Immunol 1997; 159:1182-1191.
28. Pantaleo G, Koenig S, Baseler M, Lane HC, Fauci AS. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population. J Immunol 1990; 144:1696-1704.
29. Ely KH, Cauley LS, Roberts AD, Brennan JW, Cookenham T, Woodland DL. Nonspecific recruitment of memory CD8+ T cells to the lung airways during respiratory virus infections. J Immunol 2003; 170:1423-1429.
30. Marshall DR, Turner SJ, Belz GT etal. Measuring the diaspora for virus-specific CD8+ T cells. Proc Natl Acad Sci USA 2001; 98:6313-6318.
31. Duraiswamy J, Ibegbu CC, Masopust D etal. Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults. J Immunol 2011; 186:4200-4212.
32. Hokey DA, Johnson FB, Smith J etal. Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques. Eur J Immunol 2008; 38:1435-1445.
33. Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunol Rev 2010; 235:267-285.
34. Belz GT, Stevenson PG, Doherty PC. Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses. J Immunol 2000; 165:2404-2409.
35. Deckhut AM, Allan W, McMickle A etal. Prominent usage of V beta 8.3 T cells in the H-2Db-restricted response to an influenza A virus nucleoprotein epitope. J Immunol 1993; 151:2658-2666.
36. La Gruta NL, Kedzierska K, Pang K etal. A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. Proc Natl Acad Sci USA 2006; 103:994-999.
37. Moffat JM, Handel A, Doherty PC, Turner SJ, Thomas PG, La Gruta NL. Influenza epitope-specific CD8+ T cell avidity, but not cytokine polyfunctionality, can be determined by TCRbeta clonotype. J Immunol 2010; 185:6850-6856.
38. Deliyannis G, Jackson DC, Ede NJ etal. Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus. J Virol 2002; 76:4212-4221.
39. Sun J, Madan R, Karp CL, Braciale TJ. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 2009; 15:277-284.
40. Gonzalez S, Lopez-Soto A, Suarez-Alvarez B, Lopez-Vazquez A, Lopez-Larrea C. NKG2D ligands: key targets of the immune response. Trends Immunol 2008; 29:397-403.
41. Meresse B, Chen Z, Ciszewski C etal. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004; 21:357-366.
42. Verneris MR, Karami M, Baker J, Jayaswal A, Negrin RS. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells. Blood 2004; 103:3065-3072.
43. Zarozinski CC, Welsh RM. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J Exp Med 1997; 185:1629-1639.
44. Gilbertson B, Germano S, Steele P, Turner S, Fazekas de St Groth B, Cheers C. Bystander activation of CD8+ T lymphocytes during experimental mycobacterial infection. Infect Immun 2004; 72:6884-6891.
45. Kalia V, Sarkar S, Subramaniam S, Haining WN, Smith KA, Ahmed R. Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 2010; 32:91-103.
46. Kinter AL, Godbout EJ, McNally JP etal. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 2008; 181:6738-6746.
47. Bennett F, Luxenberg D, Ling V etal. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J Immunol 2003; 170:711-718.
48. Hofmeyer KA, Jeon H, Zang X. The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion. J Biomed Biotechnol 2011; 2011:451694.
49. Jin HT, Anderson AC, Tan WG etal. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA 2010; 107:14733-14738.
50. Sheppard KA, Fitz LJ, Lee JM etal. PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett 2004; 574:37-41.
51. Chen HD, Fraire AE, Joris I, Brehm MA, Welsh RM, Selin LK. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2001; 2:1067-1076.
52. Lodolce JP, Burkett PR, Boone DL, Chien M, Ma A. T cell-independent interleukin 15Ralpha signals are required for bystander proliferation. J Exp Med 2001; 194:1187-1194.
53. Wan N, Dai H, Wang T, Moore Y, Zheng XX, Dai Z. Bystander central memory but not effector memory CD8+ T cells suppress allograft rejection. J Immunol 2008; 180:113-121.
54. Cho BK, Wang C, Sugawa S, Eisen HN, Chen J. Functional differences between memory and naive CD8 T cells. Proc Natl Acad Sci USA 1999; 96:2976-2981.
55. Ku CC, Murakami M, Sakamoto A, Kappler J, Marrack P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 2000; 288:675-678.
56. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998; 101:643-649.
57. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLOS Pathog 2008; 4:e1000115.
58. Clark RA, Chong B, Mirchandani N etal. The vast majority of CLA+ T cells are resident in normal skin. J Immunol 2006; 176:4431-4439.
59. Purwar R, Campbell J, Murphy G, Richards WG, Clark RA, Kupper TS. Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity. PLOS One 2011; 6:e16245.
60. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291:2413-2417.
61. Bourgeois C, Stockinger B. CD25+CD4+ regulatory T cells and memory T cells prevent lymphopenia-induced proliferation of naive T cells in transient states of lymphopenia. J Immunol 2006; 177:4558-4566.
62. Das G, Vohra H, Saha B, Mishra GC. Th1-specific bystander costimulation imparts resistance against Mycobacterium tuberculosis infection. Scand J Immunol 2000; 52:515-518.
63. Guerra N, Tan YX, Joncker NT etal. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 2008; 28:571-580.
64. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003; 3:781-790.
65. Walsh KB, Lanier LL, Lane TE. NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis. J Virol 2008; 82:3031-3044.
66. Ward J, Bonaparte M, Sacks J etal. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood 2007; 110:1207-1214.
67. Ogawa T, Tsuji-Kawahara S, Yuasa T etal. Natural killer cells recognize Friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions in vivo. J Virol 2011; 85:5423-5435.
68. Draghi M, Pashine A, Sanjanwala B etal. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J Immunol 2007; 178:2688-2698.